Cervivax

Cervivax

Propietary therapeutic Vaccine against Cervical Intrauterine Neoplastia based on Q-VLP propietary technology.

Page under construction

 

Technology Overview

  • 1

    Virus Like Particles

    Virus Like Particles (VLP) consist of non-infectious empty viral capsids. These particles resemble the virus from which they were derived but lack viral nucleic acid, meaning that they are not infectious.

  • 1

    Q-VLP Platform

    VLPbio patented and propietary technology platform based on Virus Like Particles derived from Infectious Bursal Disease Virus (IBDV)

  • 1

    Cervivax

    Propietary therapeutic Vaccine against Cervical Intrauterine Neoplastia based on Q-VLP propietary technology.